• All
• Nov. 28(Thu)
• Nov. 29(Fri)
• Nov. 30(Sat)

• Basic/Translational Symposium
• Big Data Research
• Combined Symposium
• Gender Specific Medicine in Gastroenterology
• In-depth Symposium
• Joint Symposium
• Korean GI Frontier
• Meet the Professor
• Metabolism & Obesity
• Multidisciplinary Session
• Nursing Session
• PG Course
• Presidential & Special Lecture
• Primary Care Session
• Symposium
• Video Session
• Plenary Session
• Topic Forum
• E-poster Oral
• General Meeting
• Editor Session
• Free Paper
• E-poster Exhibition
• Luncheon Symposium
• Breakfast Symposium

Symposium 01 (KASL1)  Korean 

Nov. 28(Thu) 09:00-10:30	Noticeable research of liver disease in year 2019	Convention Hall A+B (4F)
Chair(s)	Jung-Hwan Yoon (Korea), Kwan Soo Byun (Korea)
09:00-09:22	Viral hepatitis	Hyung Joon Yim (Korea)
09:22-09:44	Alcohol-related and non-alcoholic fatty liver diseases	Yong Kyun Cho (Korea)
09:44-10:06	Liver cirrhosis and complications	Moon Young Kim (Korea)
10:06-10:28	Hepatocellular carcinoma	Ju Hyun Shim (Korea)

Symposium 02 (KSNM1)  English 

Nov. 28(Thu) 11:00-12:30	Updates in GERD	Emerald Hall B (3F)
Chair(s)	Sung Pyo Hong (Korea), Suck Chei Choi (Korea)
11:00-11:22	Novel new options in the medical management of GERD	Nayoung Kim (Korea)
11:22-11:44	Usefulness of esophageal impedance measurement in diagnosis of GERD	Daniel Sifrim (UK)
11:44-12:06	The Lyon Consensus; how is it differ from previous ones?	Edoardo Savarino (Italy)
12:06-12:28	Current status of endoscopic management in GERD	Yuto Shimamura (Japan)

Symposium 03 (KASL2)  Korean 

Nov. 28(Thu) 14:00-15:30	Modulation of gut-liver axis in liver diseases: How far have we come?	Convention Hall A+B (4F)
Chair(s)	Jin Mo Yang (Korea), Kwang Cheol Koh (Korea)
14:00-14:20	Serotonin signals through a gut-liver axis to regulate hepatic steatosis	Hail Kim (Korea)
14:20-14:40	Dysbiosis in patients with liver cirrhosis	Do Seon Song (Korea)
14:40-15:00	Gut microbiome and hepatocarcinogenesis	Su Jong Yu (Korea)
15:00-15:20	Modulation of gut-liver axis in liver diseases: How far have we come?	Ki Tae Suk (Korea)
15:20-15:30	Discussion

Symposium 04 (KASL3)  Korean 

Nov. 28(Thu) 16:00-17:30	Recent updates in management of liver diseases	Convention Hall A+B (4F)
Chair(s)	Kwang-Hyub Han (Korea), Han Chu Lee (Korea)
16:00-16:20	Clinical development of new HBV therapies	Sang Hoon Ahn (Korea)
16:20-16:40	Management of diabetes and dyslipidemia in patients with nonalcoholic steatohepatitis	Seung-Hyun Ko (Korea)
16:40-17:00	Autoimmune hepatitis in real practice	Kang Mo Kim (Korea)
17:00-17:20	Local ablation therapy of hepatocellular carcinoma	Seung Kak Shin (Korea)
17:20-17:30	Discussion